Literature DB >> 28924725

HIV Viral Suppression, 37 States and the District of Columbia, 2014.

Kristen L Hess1, H Irene Hall2.   

Abstract

Achieving viral suppression among HIV-positive persons is a critical component of HIV treatment and prevention, because it leads to improved health outcomes for the individual and reduced risk of HIV transmission. There is wide variation in viral suppression across jurisdictions, races/ethnicities, age groups, and transmission risk groups. This analysis uses HIV surveillance data to examine rates of viral suppression among people living with diagnosed HIV (PLWDH) in 38 jurisdictions with complete lab reporting. Among people who received a diagnosis in 2014, the percentage with viral suppression within 12 months of diagnosis and the average time to viral suppression was assessed. Overall, among PLWDH in 2014, 57.9% were virally suppressed, and, among people with HIV diagnosed in 2014, 68.2% were suppressed within 12 months of diagnosis with an average time to suppression of 6.9 months. All outcomes varied by jurisdiction, but most had similar patterns of disparities with a few exceptions. These data highlight the need for tailored interventions at the local level. In addition, jurisdictions with relatively low viral suppression among particular groups could adapt effective interventions from jurisdictions who have higher rates of suppression.

Entities:  

Keywords:  HIV; Health disparities; Race/ethnicity; Viral suppression

Mesh:

Substances:

Year:  2018        PMID: 28924725      PMCID: PMC5832529          DOI: 10.1007/s10900-017-0427-3

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  5 in total

1.  An Exploratory Study to Assess Individual and Structural Level Barriers Associated With Poor Retention and Re-engagement in Care Among Persons Living With HIV/AIDS.

Authors:  Jonathan Colasanti; Natalie Stahl; Eugene W Farber; Carlos Del Rio; Wendy S Armstrong
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

2.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

3.  Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach.

Authors:  Kathleen McDavid Harrison; Tebitha Kajese; H Irene Hall; Ruiguang Song
Journal:  Public Health Rep       Date:  2008 Sep-Oct       Impact factor: 2.792

4.  Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.

Authors:  Jairam R Lingappa; James P Hughes; Richard S Wang; Jared M Baeten; Connie Celum; Glenda E Gray; Wendy S Stevens; Deborah Donnell; Mary S Campbell; Carey Farquhar; M Essex; James I Mullins; Robert W Coombs; Helen Rees; Lawrence Corey; Anna Wald
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

5.  Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Judith A Aberg; Joel E Gallant; Khalil G Ghanem; Patricia Emmanuel; Barry S Zingman; Michael A Horberg
Journal:  Clin Infect Dis       Date:  2014-01       Impact factor: 9.079

  5 in total
  3 in total

1.  Mentoring Programs by and for a New Generation of Latino Investigators in Behavioral-Social Science HIV Research.

Authors:  David M Stoff; Maria Cecilia Zea; Carlos E Rodriguez-Diaz
Journal:  Ethn Dis       Date:  2020-04-23       Impact factor: 1.847

Review 2.  The Ryan White HIV/AIDS Program after the Patient Protection and Affordable Care Act full implementation: a critical review of predictions, evidence, and future directions.

Authors:  Tamar Ginossar; John Oetzel; Lindsay Van Meter; Andrew A Gans; Joel E Gallant
Journal:  Top Antivir Med       Date:  2019-09

3.  Predictors of antiretroviral therapy interruptions and factors influencing return to care at the Nkolndongo Health District, Cameroon.

Authors:  Marius Nsoh; Katayi E Tshimwanga; Busi A Ngum; Avelina Mgasa; Moses O Otieno; Bokwena Moali; Nathanael Sirili; Ndeso S Atanga; Gregory E Halle-Ekane
Journal:  Afr Health Sci       Date:  2021-05       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.